Oculam, Adelaida .
HRN: 10-74-94 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2025
CEFTRIAXONE 1G (VIAL)
06/07/2025
06/14/2025
IV
2 Grams
Q24
T/C Thyroid CA
Checking Initial Appropriateness
07/29/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/29/2025
08/05/2025
IV
1.5g
Q6
Bleeding Thyroid Carcinoma
Checking Initial Appropriateness
08/04/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/04/2025
08/11/2025
IV
1.5g
Q6hrs
Bleeding Thyroid CA
Checking Initial Appropriateness